Evidence map›Paper›PMID 40152795›Full record

ArticleJournal of managed care & specialty pharmacy2025

Group-based trajectory modeling to identify longitudinal patterns and predictors of adherence among older adults on concomitant triple therapy (oral antidiabetic, renin-angiotensin-system antagonists, statins).

Sai S Cheruvu, Bilqees Fatima, Susan Abughosh

Abstract read
In one paragraph

Article in Journal of managed care & specialty pharmacy, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Fluctuations in adherence to antihypertensive medication and cardiovascular outcomes: a secondary analysis of the SPRINT trial.Hypertension research : official journal of the Japanese Society of Hypertension · 2026
    Trial
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Sai S CheruvuPharmaceutical Health Outcomes and Policy, University of Houston, TX.
Bilqees FatimaPharmaceutical Health Outcomes and Policy, University of Houston, TX.
Susan AbughoshPharmaceutical Health Outcomes and Policy, University of Houston, TX.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundDiabetes, hypertension, and hyperlipidemia frequently co-occur in older adults, significantly increasing their risk for cardiovascular disease, a leading cause of mortality in the United States. Managing these conditions often requires concomitant triple therapy, which includes antihypertensives, oral antidiabetics, and statins. Although medication adherence is critical for reducing cardiovascular risk, adherence to complex regimens is often suboptimal in older populations, further complicating disease management. Medicare's STAR metrics assess adherence to these medications as a measure of care quality. Traditional methods, like the proportion of days covered (PDC), provide single adherence estimates, but fail to capture the dynamic nature of adherence over time. Group-based trajectory modeling (GBTM) offers a more comprehensive approach, graphically depicting patterns of adherence behavior. This study seeks to understand longitudinal patterns and predictors of adherence of concurrent triple therapy among elderly patients under Managed Care using GBTM.

objectiveTo evaluate adherence patterns to concurrent triple therapy (antidiabetic, antihypertensive, and lipid-lowering medications) among older patients using GBTM and identify predictors associated with each adherence trajectory.

methodsPatients on concurrent triple therapy were identified using a Texas Medicare Advantage dataset from July 2016 to December 2016. Patients included had an overlap of 30 days of triple therapy, a second prescription of each component of triple therapy within the identification period, and a 12-month follow-up after the triple therapy. Monthly adherence was measured using PDC during follow-up. Patients were defined as adherent if they had at least 80% (24 out of the 30 days) covered for all 3 medications. The monthly PDC was incorporated into a logistic GBTM to provide distinct patterns of adherence. Two to five adherence groups were estimated using the second-order polynomial function of time. Predictors of adherence were identified using multinomial logistic regression, guided by the Anderson Behavioral Model.

resultsOf the 7,847 patients included, the following 4 distinct adherence trajectories were identified: adherent (42.5%), gaps in adherence (28.9%), gradual decline (13.4%), and rapid decline (15.3%). Female patients had higher odds of being in the gaps in adherence or rapid decline groups compared with males. Low-income subsidy recipients were less likely to experience rapid decline. Prior hospitalizations increased the likelihood of rapid decline in adherence.

conclusionsThis study identified heterogeneous adherence patterns among older adults on triple therapy for cardiovascular disease risk factors. Targeted interventions tailored to specific adherence trajectories are needed to improve medication adherence and health outcomes in this high-risk population.

Indexed as

Angiotensin Receptor AntagonistsAntihypertensive AgentsHydroxymethylglutaryl-CoA Reductase InhibitorsHypoglycemic AgentsAdministration, OralAgedAged, 80 and overDiabetes MellitusDrug Therapy, CombinationFemaleHumansHypertensionLongitudinal StudiesMaleMedication AdherenceUnited StatesAngiotensin Receptor AntagonistsAntihypertensive AgentsHydroxymethylglutaryl-CoA Reductase InhibitorsHypoglycemic Agents

Identifiers

PMID40152795
PMCPMC11953873

What OpenQuestion holds

Texttitle and abstract
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.